Optimizing Treatment on Idiopathic Inflammatory Myopathies
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset. This scheme is an internal routine protocol of our Service.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Idiopathic inflammatory myopathies
Locations
Other Locations
Brazil
Samuel Katsuyuki Shinjo
RECRUITING
São Paulo
Contact Information
Primary
Samuel K Shinjo, PhD
samuel.shinjo@gmail.com
55-11-3061-7176
Time Frame
Start Date: 2005-01
Estimated Completion Date: 2024-12-04
Participants
Target number of participants: 60
Treatments
Idiopathic inflammatory myopathies 1
Intravenous infusion with methyprednisolone / human intravenous immunoglobulin at disease onset
Idiopathic inflammatory myopathies 2
Intravenous infusion with methyprednisolone at disease onset
Related Therapeutic Areas
Sponsors
Leads: University of Sao Paulo